Acute psychosis after injection of pegylated interferon alpha-2a.
Thome
J
J
Knopf
U
U
D000328:Adult; D014150:Antipsychotic Agents / Q000627:therapeutic use; D005260:Female; D006526:Hepatitis C / Q000188:drug therapy*; D006801:Humans; D006993:Hypnotics and Sedatives / Q000627:therapeutic use; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000008:administration & dosage / Q000009:adverse effects*; D011092:Polyethylene Glycols / Q000008:administration & dosage / Q000009:adverse effects*; D011618:Psychotic Disorders / Q000188:drug therapy / Q000209:etiology*; D011994:Recombinant Proteins; D016896:Treatment Outcome
D014150:Antipsychotic Agents; D006993:Hypnotics and Sedatives; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D011092:Polyethylene Glycols; C100416:peginterferon alfa-2a